Skip to main content
Clinical Trials/NCT06814093
NCT06814093Active, not recruitingNot Applicable

Robotic Versus Laparoscopic Surgery for Middle and Low Rectal Cancer: A Retrospective Cohort Study Emulating the Target Trial

Xu jianmin1 site in 1 country2,702 target enrollmentStarted: January 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
2,702
Locations
1
Primary Endpoint
3-year postoperative disease-free survival rate

Study Overview

Brief Summary

This study aims to compare the effectiveness of robotic surgery versus laparoscopic surgery in treating low rectal cancer. While robotic surgery has gained popularity, there is limited long-term evidence regarding its outcomes. By using real-world data from a specialized multicenter colorectal cancer database in Shanghai, China, this retrospective cohort study will emulate the target trial to evaluate whether robotic surgery offers advantages over laparoscopic surgery. Key factors such as disease-free survival, locoregional recurrence, circumferential margin positivity, and postoperative complications will be examined. The goal is to provide stronger, evidence-based support for the clinical use of robotic surgery in treating low rectal cancer.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

3-year postoperative disease-free survival rate

Time Frame: From surgery to three years postoperatively

Disease-free survival event is defined as any death or locoregional recurrence or distant metastases.

Secondary Outcomes

  • Circumferential resection margin positivity rate(14 days during postoperative pathological examination)
  • 30-day postoperative complication rate (Clavien-Dindo grade 2 or higher grade)(From surgery to 30 days postoperatively)
  • rate of abdominoperineal resection(30 days after surgery)
  • 3-year postoperative locoregional recurrence rate(From surgery to three years postoperatively)

Investigators

Sponsor
Xu jianmin
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Xu jianmin

Director of Colorectal Surgery

Fudan University

Study Sites (1)

Loading locations...

Similar Trials